Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Vertex Pharmaceuticals announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene ...

Sublingual Allergy Immunotherapy Market The rising of allergic diseases, such as allergic rhinitis and asthma, is a factor driving the grow ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Vertex Pharmaceuticals (VRTX – ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...